Medicines update

Neuro risk prompts metoclopramide PI change

Product Information for the antiemetic and gastroprokinetic drug metoclopramide has been updated to include a new contraindication to reduce the risk of neurological adverse events.

There are also changes to the drug’s dosing and duration of use, as revealed by the TGA in its latest Medicines Safety Update.

The TGA said it has received 2190